Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci
Gestores bibliográficos
Compartir
Authors
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
9
item.page.accessRights
item.page.other
item.page.references
Abstract
Treatment of severe infections caused by vancomycin-resistant enterococci (VRE) is challenging due to the scarcity of reliable therapeutic alternatives. In this context, daptomycin (DAP), a lipopeptid...
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
Int J Antimicrob Agents. 2014 Nov;44(5):387-395
Keywords
item.page.dc.rights
item.page.dc.rights.url
Estadísticas de uso
1 0,8 0,5 0,3 0
Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026Marzo 2026